ELV vs HUM stock comparison
Elevance Health vs. Humana · data as of November 13, 2026
Elevance Health (ELV) has a market value of about $92.8B, Humana (HUM) about $54.0B. Over their latest twelve months Elevance Health had revenue of $201.8B and Humana $154.2B.
On our five checks Elevance Health scores higher: 3.0 out of 5 (average) against 2.4 (weak).
By area, the stronger company is Elevance Health on value; Humana on future growth; Elevance Health on financial health; Elevance Health on shareholder returns.
Elevance Health is cheaper on earnings (P/E 18.3 vs. 43.7), while Humana grew revenue faster over five years (10.9% vs. 10.3% a year).
Elevance Health leads on 17 of the compared lines and Humana on 5.
Side by side
| ELV | HUM | |
|---|---|---|
| Size and price | ||
| Market cap | $92.8B | $54.0B |
| Share price | $429.69 | $450.00 |
| Score | ||
| Overall score (of 5) | 3.0 | 2.4 |
| Value | 4 | 2 |
| Future growth | 1 | 2 |
| Track record | 2 | 2 |
| Financial health | 3 | 2 |
| Shareholder returns | 5 | 4 |
| Valuation | ||
| P/E (TTM) | 18.3 | 43.7 |
| Forward P/E | 14.6 | 30.6 |
| Price / free cash flow | 14.3 | 17.2 |
| Price / sales | 0.5 | 0.4 |
| EV / EBITDA | 12.7 | 13.7 |
| PEG | 2.61 | — |
| DCF value vs. price | +1% | +15% |
| Business | ||
| Revenue | $201.8B | $154.2B |
| Net income | $5.1B | $1.2B |
| Free cash flow | $6.5B | $3.1B |
| Net margin | 2.5% | 0.8% |
| Gross margin (5-yr avg.) | 90.4% | — |
| ROIC (5-yr avg.) | 9.3% | 9.0% |
| Growth | ||
| Revenue growth (1 yr) | 12.5% | 10.1% |
| Revenue growth (5 yrs, per year) | 10.3% | 10.9% |
| EPS growth (5 yrs, per year) | 7.0% | -17.2% |
| Balance sheet and payouts | ||
| Net cash (cash minus debt) | $4.9B | $12.6B |
| Dividend yield | 1.60% | 0.79% |
| Shareholder yield | 4.4% | 1.1% |
| Analysts | ||
| Upside to average target | +12% | +10% |
| Consensus rating | Buy | Buy |
Highlighted = the better figure on that line. Revenue, net income and free cash flow: ELV TTM to September 30, 2026, HUM TTM to September 30, 2026. Not investment advice.
Frequently asked questions
Which is the better stock, Elevance Health or Humana?
We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) Elevance Health scores 3.0 out of 5 and Humana 2.4; the table shows where each one is stronger.
Is Elevance Health cheaper than Humana?
On trailing earnings, Elevance Health trades at a P/E of 18.3 and Humana at 43.7, so Elevance Health is cheaper by this measure. A lower P/E can also reflect slower expected growth.
Which grows faster, Elevance Health or Humana?
Over five years Humana grew revenue about 10.9% a year and Elevance Health about 10.3% a year.
Which pays a higher dividend?
Elevance Health yields 1.60% and Humana 0.79%.
Full Elevance Health analysis → Full Humana analysis →
More comparisons
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.